Integrated Analysis of Multi-Omic Data Reveals Regulatory Mechanisms and Network Characteristics in Breast Cancer

Zahra Hosseinpour1, Mostafa Rezaei Tavirani2, Mohammad Esmaeil Akbari3

  • 1Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abstract

Insights

This study identified eight key upregulated genes in breast cancer by analyzing multi-omic data. These findings offer insights into breast cancer

Area of Science:

  • Genomics and Molecular Biology
  • Cancer Research
  • Bioinformatics

Background:

  • Breast cancer is a complex disease requiring understanding of its regulatory networks.
  • Identifying therapeutic targets necessitates knowledge of gene, miRNA, and protein interactions.
  • Multi-omic data integration is crucial for unraveling disease mechanisms.

Purpose of the Study:

  • To investigate the interaction network of differentially expressed genes, miRNAs, and proteins in breast cancer.
  • To identify potential therapeutic targets through integrative analysis of multi-omic data.
  • To understand the regulatory mechanisms and network characteristics of breast cancer.

Main Methods:

  • Utilized the Cancer Genome Atlas Breast Invasive Carcinoma (TCGA-BRCA) dataset.
  • Performed integrated analysis of RNA sequencing, miRNA sequencing, and protein quantification data.
  • Employed differential expression analysis, network construction, and pathway enrichment analysis.

Main Results:

  • Identified eight consistently upregulated hub genes: ACTB, HSP90AA1, FN1, HSPA8, CDC42, CDH1, UBC, and EP300.
  • Discovered enriched pathways including 'proteoglycans in cancer', 'PI3K-Akt signaling', and 'mitogen-activated protein kinase signaling'.
  • Established potential significance of identified genes in driving breast cancer progression.

Conclusions:

  • Integrated multi-omic analysis provides insights into breast cancer regulatory networks.
  • Findings facilitate the identification of novel therapeutic targets.
  • Contributes to a deeper understanding of breast cancer's molecular landscape and treatment strategies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
36.2K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328